Study of changes in serum levels of creatine kinase and liver enzymes in organophosphorus poisoning and it’s prognostic significance by Senthil Kumaran, A
“STUDY OF CHANGES IN SERUM LEVELS OF
CREATINE KINASE AND LIVER ENZYMES IN
ORGANOPHOSPHORUS POISONING AND IT’S
PROGNOSTIC SIGNIFICANCE”
Dissertation submitted to
THE TAMILNADU DR.M.G.R.MEDICAL UNIVERSITY
in partial fulfillment of the regulations
for the award of the degree of
M.D. BRANCH – I
GENERAL MEDICINE
CHENGALPATTU MEDICAL COLLEGE
THE TAMILNADU DR.
CHENNAI M.G.R.MEDICAL UNIVERSITY, INDIA.
APRIL 2015.
CERTIFICATE
Certified that this dissertation entitled “STUDY OF CHANGES IN
SERUM LEVELS OF  CREATINE KINASE AND LIVER
ENZYMES IN ORGANOPHOSPHORUS POISONING
AND IT’S PROGNOSTIC SIGNIFICANCE”is a bonafide work
done by Dr.A.Senthil Kumaran, post graduate student of the Department of
General Medicine, Chengalpattu Medical College, Chengalpattu, during the
academic year 2012-2015. This work has not previously formed the basis for the
award of any degree.
Prof . Dr. K. Srinivasagalu, M.D. Prof. Dr.Raja Billy Abraham, M.S.,
Head of Department, Dean
Department of General Medicine, Chengalpattu Medical College & Hospital,
Chengalpattu Medical College & Hospital, Chengalpattu.
Chengalpattu.
DECLARATION
I Dr.A.Senthil kumaran, solemnly declare that the dissertation titled,
“STUDY OF CHANGES IN SERUM LEVELS OF
CREATINE KINASE AND LIVER ENZYMES IN
ORGANOPHOSPHORUS POISONING AND IT’S
PROGNOSTIC SIGNIFICANCE” is a bonafide work done by me at
Chengalpattu Medical College during 2011-2014 under the guidance and
supervision of Prof. Dr.KULOTHUNGAN,M.D., Professor, Department of
General Medicine, Chengalpattu Medical College, Chengalpattu. The dissertation
is submitted to The Tamilnadu Dr. M.G.R. Medical University, towards partial
fulfillment of requirement for the award of M.D. (General Medicine)
Place: Chengalpattu Dr.A.Senthil kumaran
Date :
SPECIAL ACKNOWLEDGEMENT
I gratefully acknowledge and sincerely thank
Prof. DR.RAJA BILLY ABRAHAM, M.S.,
DEAN
CHENGALPATTU MEDICAL COLLEGE AND HOSPITAL,
CHENGALPATTU.
For granting me permission to utilize the resources of this
institution for my study.
ACKNOWLEDGEMENT
I would like to take this opportunity to express my deep sense of
gratitude towards Dr.R.KULOTHUNGAN.M.D., Professor,
Department of Medicine, Chengalpattu Medical College, Chengalpattu
for his valuable guidance, constant encouragement, and expert
suggestions, in spite of his busy schedule, which was most crucial in
overcoming various difficulties. I will remain thankful for his guidance,
inspiration and constant support.
I am extremely grateful to Dr.K.Srinivasagalu. M.D., Professor and
Head of the Department of General Medicine, Chengalpattu Medical
College, Chengalpattu for his supervision and keen interest in academic
activities.
I am thankful to Dr.R.Muthuselvan.M.D., Dr.G.Rajan.M.D.,
Dr.S.MohanRao.M.D., Dr.Rajalakshmi.M.D., Professors of Medicine
for their guidance and timely help.
I am indebted to Dr.Arulanandham.M.D., Dr.S.Sudha.M.D.,
Dr.Narendhiran.M.D., Assistant Professors of Medicine for their
guidance and help given during my course and thesis work.
I am extremely thankful to my friend, junior and colleagues for their
untiring support.
I thank all others who have assisted me in some form or other in
preparation of my thesis.
I would like to thank my parents and my brother who constantly
encouraged me and gave moral support.
Last but not the least; I am grateful to all those patients who were the
subjects for this study, without whose co-operation this work would
not have been possible.
I bow my head in respect before God Almighty
Date: Signature of the Candidate
Place: Chengalpattu Name:Dr.A.Senthil Kumaran
TABLE OF CONTENTS
S.No. Title Page No.
1. AIMS OF THE STUDY 1
2. REVIEW OF LITERATURE 2
3. INTRODUCTION 4
4. MATERIAL AND METHODS USED 55
5. RESULTS AND ANALYSIS 56
6. DISCUSSION 93
7. LIMITATIONS OF STUDY 99
8. SUMMARY 100
9. BIBLIOGRAPHY 102
10. PROFORMA 111
11. MASTER CHART
List of tables
S NO Particulars
1 Classification of OP compounds. 10
2 Symptoms of OP poisoning. 37
3 Peradeniya scale of OP poisoning. 43
4 Age distribution of OP poisoning. 56
5 Distribution of patients according to their sex 58
6 Distribution of patients according to the type of OP compound
consumed
60
7 Distribution of patients according to their peradeniya score 62
8 Distribution of patients according to their occupation 64
9 Distribution of patients according to their residence 66
10 Distribution of patients according to their route of
administration
68
11 Manner of distribution of organophosphorus poisoning 70
12 Distribution of patients according to the clinical features 72
13 Association of mild severity by peradeniya score of
organophosphorus(POP) with CPK,SGOT and SGPT.
74
14 Association of moderate severity by peradeniya score of
organophosphorus(POP) with CPK,SGOT and SGPT.
76
15 Association of severe severity by peradeniya score of
organophosphorus(POP) with CPK,SGOT and SGPT.
78
16 POP* levels of CPK crosstabulation. 80
17 POP *levels of SGOT crosstabulation 81
18 POP*levels of SGPT crosstbulation. 82
19 correlation of POP with levels of CPK,SGOT and SGPT. 83
20 prognosis vs CPK levels crosstab. 84
21 prognosis vs SGOT crosstab 85
22 prognosis vs SGPT crosstab. 86
23 Association of respiratory failure in organophosphorus
poisoning with CPK,SGOT and SGPT.
87
24 Association of intermediate syndrome in organophosphorus
poisoning with CPK,SGOT and SGPT.
89
25 Association of death in organophosphorus poisoning with
CPK,SGOT and SGPT.
91
List of chart
1 Distribution of patients according to their age group 57
2 Distribution of patients according to their sex 59
3 Distribution of patients according to the type of
organophosphorus compound consumed
61
4 Distribution of patients according to their peradeniya
score
63
5 distribution of patients according to their occupation. 65
6 distribution of patients according to their residence 67
7 distribution of patients according to their route of
administration.
69
8 manner of distribution of organophosphorus poisoning. 71
9 distribution of patients according to their symptoms 73
10 Association of mild severity by peradeniya score of
organophosphorus(POP) with CPK,SGOT and SGPT
75
11 Association of moderate severity by peradeniya score of
organophosphorus(POP) with CPK,SGOT and SGPT.
77
12 Association of severe severity by peradeniya score of
organophosphorus(POP) with CPK,SGOT and SGPT.
79
13 Association of respiratory failure in organophosphorus
poisoning with CPK,SGOT and SGPT
88
14 Association of intermediate syndrome in
organophosphorus poisoning with CPK,SGOT and SGPT
90
15 Association of death in organophosphorus poisoning with
CPK,SGOT and SGPT
92


LIST OF ABBREVIATIONS
Ach Acetylcholine
Anti- ChE Anticholinesterase
AOPP Acute organophosphorus poisoning
AST Aspartate transaminase
CPK Creatinine phospho Kinase
CNS Central nervous system
CT Concentration time
CYP Cytochrome P
DDT Dichlorodiethyltrichloroethane
ECG Electrocardiogram
ELISA Enzyme linked immunosorbent assay
EPA Environmental protection agency
GABA Gama amino butyric acid
GDP Gross domestic product
GI Gastrointestinal
HI-6 Asoxime
ICU Intensive care unit
IFCC International Federation of Clinical Chemistry
IM Intramuscular
IMS Intermediate syndrome
IV Intravenous
LD50 Lethal Dose 50%
LDH Lactate dehydrogenase
LFT           Liver function test
LuH-6 Obidoxime
NCRB National crime records bureeau
NMJ Neuromuscular junction
NTE Neuropathy target esterase
OP            Organophosphorus
OPIDN      Organophosphate-induced delayed neuropathy
PAM-2       Pralidoxime
PON1       Paraoxonase 1
POP          Peradeniya organophosphorus scale
PPE           Personal protective equipment
RBC           Red blood cells
RCT          Randomised controlled trial
RSI           Rapid sequence intubation
SGOT         Serum glutamic oxaloacetic transaminase
SGPT         Serum glutamic pyruvate transaminase
TEPP         Tetraethyl pyrophosphate
TMB-4        Trimedoxime
WHO          World health organization
CERTIFICATE
Certified that this dissertation entitled “STUDY OF CHANGES IN
SERUM LEVELS OF  CREATINE KINASE AND LIVER
ENZYMES IN ORGANOPHOSPHORUS POISONING
AND IT’S PROGNOSTIC SIGNIFICANCE”is a bonafide work
done by Dr.A.Senthil Kumaran, post graduate student of the Department of
General Medicine, Chengalpattu Medical College, Chengalpattu, during the
academic year 2012-2015. This work has not previously formed the basis for the
award of any degree.
Signature of the guide
Prof. R . Kulothungan,M.D.,
Department of medicine,
CMCH.
~ 1 ~
AIMS AND OBJECTIVES
1. To study the changes in serum levels of hepatic enzymes and serum creatine
phosphokinase in patients with organophosphorus compound poisoning.
2. To study the prognostic significance of hepatic enzymes and creatine
phosphokinase in patients with organophosphorus compound poisoning.
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REVIEW OF  LITERATURE
Dr. Kuntal Bhattacharyya1, did a prospective study in 2011 in the
Department of General Medicine, Government Medical College, Kolkotta, India,
studied 63 patients of Organophosphorus poisoning to find out the level of
Creatine kinase and its prognostic significance. The serum Creatine kinase level
was estimated for 61 patients. Two patients (Initial CPK 1138 IU/L & 1086 IU/L)
collapsed out of complications during the course of therapy on day 3 & day 5
respectively.
It was found that mortality was more in patients with high initial CPK
level. Another  3 patients  developed intermediate  syndrome on day 3, had initial
Creatine kinase level 1138 IU/L & concluded serum Creatine kinase can be an
efficient biomarker in case of acute Organophosphorus poisoning.
S.B. Agarwal and V.K. Bhatnagar2, in the year 2007 conducted a
prospective study in acute OPC poisoning patients treated in the In-Patient Dept. of
General Medicine, B.J.M.C.H, Ahmedabad. 121 patients were studied and found
that the levels of serum LDH and Creatine kinase levels were markedly elevated
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among poisoning cases indicating muscular impairment due to Organophosphorus
toxicity. The Creatine kinase level was markedly increased among poison cases
and there was high elevation in patients who collapsed.
A.Patel, V.Shivgotra & V.Bhatnagar3, in the year 2008 conducted a
prospective study in workers engaged in Organophosphorus insecticide production.
About 161 workers were involved as subjects in the study. There was 40 subjects
in control group, 50 subjects in maintenance group  and 71 subjects in exposed
group. The serum levels of SGOT & SGPT, was in the normal level in the
controlled and in the subjects, who were exposed.
Antonio F. Hernández4, in the year 2006 conducted a cohort study
involving more than 100 intensive farmers. The renal and liver parameters like
urea, creatinine, SGOT, SGPT and LDH was tested twice during the time for
spraying. Cholinesterase suppression by more than 25% was used as criteria for
estimating insecticide exposure. The results showed a correlation with increase in
SGOT, SGPT and LDH levels.
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Dilshad Khan, Mahwish Bhatti, Farooq Khan, Syed Naqvi, Karam
A5, Pathologists in Army Medical College, in 2008, conducted a prospective study
on 109 patients and concluded that butryl cholinesterase level was
significantly(P<0.001) reduced in the  farmers exposed to insecticide when
compared to controls. Biochemical parameters like SGOT, SGPT, CKP,lactate
dehydrogenase were markedly raised in the insecticide exposed agriculture
workers as compared  to control group. Total insecticide residues showed a highly
significant   correlation with SGOT, LDH, SGPT.
INTRODUCTION
Acute poisoning by Organophosphosphorous insecticide (OP) has reached
epidemic proportions in most parts of the world, particularly in developing
countries like India, where agriculture is the backbone. The toxicity of
Organophosphosphorous poisoning and paucity of appropriate medical facilities
accounts for a high fatality rate. Their ease of access and socio–cultural factors
play important role in choice of OP as a self-poison and the incidence is higher
among young economically active group with a common fatality ratio of 20%.
Insecticide compounds cause many number of suicidal deaths in South and Central
India6.
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Occupational, suicidal or homicidal exposure to OPs produces a
characteristic, but treatable syndrome in humans. Thus, early recognition and
timely intervention of toxicity from these compounds are of great importance, to
critical care providers and patients.
Case reports7 on clinical significance of liver enzymes and creatine kinase in
acute organophosphorous compound ingestion has been reported now and then, but
there are no large-scale studies with reference to clinical significance of liver
enzymes and Creatine kinase. Hence an attempt will be made to study clinical
significance of liver enzymes and Creatine kinase in OP poisoning.
HISTORY OF ORGANOPHOSPHORUS COMPOUNDS:
In this field the earliest scientists are J Loui Lssaigne and Philippe
Clermonte (early in nineteen hundred century) 8. Around 1932,chemist in germany
by name Willy Lange and his student, Gerde Krueger, was first to describe the
cholinergic CNS effects oforganophosphorus. The earliest organophosphorus
compound, tetraethyl pyrophosphate (TEPP), was produced in middle of
nineteenth century, but the compound not used till second world war, in which
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nicotine a rare pesticide was replaced by tetraethyl pyrophosphate. The toxicity of
organophosphorus was utilized in the secondworld war by Germans with the
production of the nerve gas agents9.
After Second World War, US companies got information from
Schrader's laboratories, and started producing organophosphorus compounds in
huge quantities. The first marketed compound was Parathion, followed by
Malathion and Azinphosmethyl. These insecticides became famous when
organochlorine insecticides like DDT, Dieldrin, and Heptachlor were banned in the
middle of twentieth century.
The mechanism of action of organophosphorus compound was understood
after the massive Jamaican ginger palsy accident which took place in the year
1930.10
STRUCTURE OF ORGANOPHOSPHATES11:
Organophosphorus are heterogenous compounds sharing similar
chemical properties. Organophosphorus has a P atom in the central group with a
double bond to O2or S (P=S) either, two side chains of organic (R1and R2), and an
~ 7 ~
side chain of additional that will act as leaving group (X). The individual
organophosphorus is specific for its leaving group which can be a CN, thio-CNate,
halide, phenoxy phosphate, thio-phenoxy, or carboxyl group. The R1and R2 can be
aryl/alkyl groups and, in many of the common insecticides, are either two ethyl or
two methyl esters that form the diethyl (diethoxy) or dimethyl (dimethoxy) OPC
respectively.
~ 8 ~
Chemical Classification of Representative Organophosphorus:
Compounds
Group A, X = halogen, cyanide, or thiocyanate leaving group;
Group B, X =alkylthio, arylthio, alkoxy, or aryloxy leaving group;
Group C, thionophosphorus orthio-thionophosphorus compounds;
Group D, pyrophosphates and similar compounds;group E, quaternary ammonium
leaving group. R1can be an alkyl (phosphonates), alkoxy (phosphorates) or an
alkylamino (phosphoramidates) group.
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structural formula of di-isopropyl fluorophosphate.
This compound belongs to group A and it is a potent irreversible in activator of
acetylcholinesteras.
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Structural formula of tabun which belongs to group A Organophosphorus
compound and it is a extremely toxic nerve gas agent.
~ 13 ~
Structural formula of sarin.
This compound belongs to group A of organophosphorus compound and it is a also
a extremely toxic nerve gas agent. It’s chemical name is isopropyl methyl
phosphonofluridate.
~ 14 ~
Structural formula of soman.
This compound also belongs to group A of organophosphorus compound. It also a
extremely toxic nerve gas agent. It’s chemical name is pinacolyl methyl
phosphonofluridate.
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Structural formula of parathion
This compound belongs to group C of organophosphorus compound. Commonly
used agricultural pesticide and it is one of common cause of accidental poisoning.
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Structural formula of diazinon
This compound belongs to group C of organophosphorus compound. It is
commonly used for agricultural and gardening purpose. It is banned for indoor use.
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Structural formula of chlorpyrifos
This compound belongs to group C of organophosphorus compound and it one of
the commonly used agricultural pesticides.
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Structural formula of malathion
Malathion belongs to group C of organophosphorus compound and it is widely
used insecticide because of it’s property of rapid detoxified by higher organism
and superior safety when compared to parathion.
~ 19 ~
Structural formula of paraoxon
This compound belongs group B of organophosphorus compound. It is a active
metabolite of parathion. It’s chemical name is o,o-diethyl,o-4-nitrophenl-
phosphate.
~ 20 ~
Structural formula of mlaoxon
Malaoxon is a active metabolite of malathion and it belongs to group B of
organophosphorus compound. It chemical name is O,O dimethyl S-(1,2-
dicarboyethyl)-phosphorothioate.
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Structural formula of TETRA ETHYL PYROPHOSPHATE
TEPP
This is one of earliest pesticide. And it belongs to group D of organophosphorus
compound.
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Structural formula of echothiophate.
This compound belongs to group E of organophosphorus compound. This is a
potent choline derivative. It is commonly used in the treatment of glaucoma. It is
highly stable in aqueous solution.
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EPIDEMIOLOGY:
Global Status:
The serious human toxicity associated with organophosphorus
compounds accounted for more than 80% of hospitalization12 related to pesticide
poisoning. In contrast to organo chlorine, organophosphorus was used because of
their unstable nature, rapid hydrolysis and no long period accumulation in
environment.
There is an increased number of poisoning due to its widespread use.
In early 1970 EPA13 conducted a survey which showed around 3000
hospitalization with insecticide poisoning in America with a case fatality rate of
around 50% in Paediatrics and ten percent in adults. In 1980’s study13 given by US
association of poison control centre showed incidence of 77000 of which the
compound is organophosphate in 33000 cases.
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A survey conducted13 in Bangaladesh showed 14% of death of females in
the age group of 10 to 50 is suicidal poisoning of which majority is due to
insecticide. The situation is worse in Sri Lanka in which insecticide poisoning is
the most commonest cause of death in 6 districts.
The WHO data shows around 9 lakhs people14 die annually due self
harm of which more than 60% of death is due to insecticide poisoning and it is
greater than self hanging and other modes of self harm.
National status:
India is an agricultural country and by far India is highly dependent on
agriculture for its GDP. Insecticide poisoning by far is very common in India due
to cheap and easily availability. Furthermore, easy accessibility to children and
lack of awareness makes insecticide poisoning common in India. Annually more
than 126000 cases have calculated to occur in the year 2007 by Gunell et al15.
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PATHOPHYSIOLOGY OF TOXICITY16:
Mode of action of organophosphates is by binding to serine active site
of Acetylcholinesterase. Due to inhibition of Acetylcholinesterase, acetylcholine
begin to accumulate at nerve endings and their by paralyzing central and peripheral
nicotic and muscuranic receptors. In normal condition acetyl cholinesterase
hydrolyses acetyl choline to choline which is used for re-synthesis. When
Acetylcholinesterase is blocked in case of poisoning acetylcholoine begins to
accumulate which initially causes excitation followed by depolarization blockade
at the post synaptic level.
Acetylcholinesterase exists in three forms true cholinesterase found in
nervous tissue and it important for physiological conduction but it is difficult to
estimate. Pseudocholinesterase is found in serum and liver and it is easily to
calculate and it is responsible for metabolism of xeno-biotics. Erythrocyte acetyl
cholinesterase is similar to true or neuronal cholinesterase and it is difficult to
calculate.
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Acetylcholinesterase is a protein structure which contains a serine binding
site and a catalytic site. Organophosphorus compounds form a reversible Michelis-
Menten complex by binding to serine enzymatic site and cause rapid
phosphorylation of the serine residue. Following that, the leaving group is ejected
from the organophosphorus compound. During this process organophosphorus
compounds binds to the enzyme on the pit and produces a conformatory change in
the enzyme and thereby preventing the binding for acetylcholine to the enzyme and
preventing enzymatic activity.
The organophosphorus bound enzyme will undergo 2 forms of
reaction. First one is aging process or irreversible in activation by breakage of one
of the R groups and this largely dependent on the nature of organophosphorus
compound. Another reaction is reactivation of enzyme by the process of hydrolysis
of the bond between the serine and organophosphorus compound. The R group
attached to the organophosphorus compound is largely responsible for the enzyme
to undergo reactivation or irreversible inactivation by aging process.
~ 28 ~Mechanism of aging of acetylcholinesterase.
~ 29 ~
Organophosphorus compounds with smaller side chains undergo faster
inactivation by aging process when compared to compounds with branching side
chains. For examples dimethyl orgophosphates compound undergo faster
inactivation when compared to diethyl organophosphorus compounds. Once the
enzyme is aged it cannot be reactivated by either in vivo hydrolysis or by oxime
treatment.
When the organophosphorus compound is consumed formation of axon
peaks which follows decline in the serum. Even after the organophosphorus
concentration in the serum decreases, Acetylcholinesterase inhibition continue to
increase by the process of covalent binding.
Even a minimal amount of Acetylcholinesterase is enough for the
normal functioning. Once this threshold is crossed even on removal the
organophosphorus compound will act to restore the enzyme function. In case of
dimethyl organophosphorus compounds enzymatic restoration occurs fast due to
smaller side chain and it is delayed in case of dimethoate due to branched side
chain. The reactivation of acetylcholinesterase with oxime is by the formation of
transient complex with phosphorylated enzymes.
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Once this formation of complex undergoes saturation kinetics further
addition of oxime shows no effect on further reactivation.
The oximes remove the organophosphorus from the Acetylcholinesterase
molecule and causes reactivation of the Acetylcholinesterase. Poisoning   with
highly lipophilic agents like fenthion, develop toxicity even after oxime therapy
due to prolonged elimination.
Anticholinesterase compound produces its toxic effects by stimulation
of muscarinic receptors followed by depression of autonomic ganglia and skeletal
muscles and depression or stimulation of muscuranic receptors in the central
nervous system.
Compounds belonging to quarternary amino groups do not penetrate
cell membrane readily. Hence compounds belonging to this group are poorly
absorbed from gastrointestinal tract or through the skin and does not penetrate
blood brain barrier.
These compounds preferentially act at neuromuscular junction of
skeletal muscles whenever highly lipophillic compounds penetrate skin and gastro
~ 31 ~
intestinal tract easily and they affect the central nervous system by readily crossing
the blood brain barrier.
PHARMACOKINETICS:
Insecticides commonly used are generally dispersed as aerosols and
are adsorbed as inert, fine particles. Insectides are absorbed directly via skin and
mucous membrane, or by inhalation to lungs, or by ingestion to gastro-intestinal
tract.
Most organophosphorus compounds are excreted through urine after
hydrolsis. Plasma and hepatic enzymes like esterases hydrolyze OPC’s to the
phosphoric and phosphonic acid derivatives.
Also, the CYPs convert the inactive phosphorothioates containing a
phosphorus-sulfur (thiono) bond to phosphorates with a phosphorusoxygen bond,
resulting in their activation.
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The organophosphorus anti-ChE agents are hydrolyzed by two types
of enzymes: a) the carboxylesterases and b) the paraoxonases (A-esterases), which
are found in the plasma and hepato-biliary system. They tend to scavenge a large
number of organophosphorus compounds by cleaving the phosphoester, anhydride,
PF, or PCN bonds. The paraoxonases are low-molecular-weight enzymes,
requiring Ca2+ for catalysis. Isoenzymes control low density lipoprotein oxidation,
thus providing a protective effect in atherosclerosis. Organophosphate substrate
specificity and susceptibility to atherosclerosis are found to have genetic
susceptibility.
Plasma and hepatic carboxylesterases (aliesterases) and plasma
butyrylcholinesterase are inhibited irreversibly by organophosphorus compounds;
These are the main scavenging enzymes of AChE in the nervous system. The
carboxylesterases also catalyze hydrolysis of malathion and other carboxyl-ester
linkage containing OPCs, rendering them less active or inactive. Since
carboxylesterases are inhibited by organophosphates, toxicity from exposure to
two organophosphorus insecticides can be synergistic.
~ 33 ~
Absorption:
The percentage of absorption depends on
a) Duration of time in contact with mucous membrane and skin.
b) Liphophilic nature of the insecticide compound consumed.
c) Volatile nature of the compound.
d) Nature of the area which comes in contact for example skin of axilla, head
and mucous membrane absorb more insecticide when compared skin of
hands and palms.
e) Type of dress worn during poisoning and it’s permeability,
f) Percentage of body uncovered and exposed to pesticide at the time of
poisoning.;
g) Molecular weight of the compound consumed. (Less molecular weight are
absorbed more quickly)
Distribution and Storage:
Organophosphorus compounds are widely stored in fat tissues and moreover
they are lipophilic which responsible for delayed toxicity even after initial apparent
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recovery. They are largely stored in salivary glands, liver and kidney. As they are
lipophilic the easily cross the blood brain barrier and affect the central nervous
system rapidly.
Elimination:
Elimination is mainly through urine and faeces. Small amount is excreted
through expired air. Dichlorvos which are not liphophilic is excreted rapidly
whereas chlorpyrifos which are liphophilic is stored in fat for longer period and are
eliminated for days.
TOXICICOLOGY:
Toxic effects of the agent largely depend on the type of compound
consumed, amount of compound consumed, route and duration of contact with the
offending agent.
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WHO17 classified the organophosphorus compound as extremely
hazardous, moderately hazardous and slightly hazardous on the basis of lethal dose
of 20-200mg/kg, 200-2000mg/kg and >2000mg/kg respectively.
Hence the lethal dose can be as low as few mgs to as high as 50 gms
for hidghly toxic and least toxic compounds respectively. For nerve agents lethal
dose may be as low as 1 mg for sarin.
CLINICAL MANIFESTATIONS OF ORGANOPHOSPHORUS
POISONING:
Acute Intoxication
Signs and symptoms of insecticide compound depend on the amount
of compound consumed, route of administration and nature of compound and
duration of contact with the offending agent.
After exposure symptoms include constriction of pupils, ciliary paralysis,
congestion of conjunctiva and painful eye. With systemic intoxication constriction
pupils will not be evident due sympathetic stimulation due to hypotension.
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Respiratory symptoms are due to rhinnorhea hypersecretion in the
respiratory tract. Chest discomfort and wheezing are due to increased secretion in
the bronchial airways. Gastro intestinal symptoms include nausea, vomiting,
abdominal pain and diarrhea.
Severe toxicity manifest as involuntary defecation and urination, increased
lacrimation, bradycardia and hypotension, severe muscle weakness and paralysis.
CNS manifestation include confusion, ataxia, rapid breathing (Chynes-Stokes),
generalized convulsion, coma, respiratory paresis and hypotension.
Death can occur from insecticide poisoning from as short as 5 minutes to 24
hours depending on the type of compound consumed, route of administration,
amount of compound consumed and time delay in presentation.
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Muscarinic Nicotinic Central
Increased salivation
Increased lacrimation
Increased urination
Increased defecation
Abdominal cramps
Vomiting
Miosis
Respiratory difficulty
Faecal and urinary
incontinence
Hypertension
Tachycardia
Muscle weakness/paralysis
Muscle fasciculation
Pallor
Mydriasis
Confusion
Convulsions
Psychosis
Fatigue
Respiratory depression
Ataxia
Dysarthria
anxiety
Table 2 : symptoms of OP poisoning .
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Symptoms of organophosphorus poisoning.
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INTERMEDIATE SYNDROME
In 1987, Senanayake18 defined a condition which occurs on second to third
day after cholinergic crisis and it is characterized by proximal muscle weakness,
neck muscle weakness and respiratory failure.
The syndrome has been characterized by absent muscarinic symptoms but
continued severe acetylcholinesterase inhibition as measured by cholinesterase
activity, and there is no therapy other than supportive care. There is no definite
etiology or treatment for intermediate syndrome. Treatment is mostly supportive
therapy. But some authors recommend addition oximes for intermediate syndrome
with no definite results.
TOXIC DELAYED POLYNEUROPATHY DUE TO OPC:
Organophosphorus compounds inhibit neuropathy target esterase which
on loss causes demyelination of axons. This causes symptoms like paraesthesia,
pain and distal muscle weakness which usually starts after 6 weeks of illness and
may progress upto 6 months. There is no definite treatment for this condition and it
is diagnosed by estimating lymphocyte NTE assay.
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OTHER RELATED DISORDERS:
There are other delayed neuropsychological effects like fatigue, confusion,
dementia and depression.
DIAGNOSIS:
Diagnosis is mainly clinical. History of exposure to a known OP compound
must be elicited, wherever possible. Estimation of serum or RBC cholinesterase
level is the investigation of choice and clinches the diagnosis of OPC poisoning.
Electrodiagnostic tests may be helpful.
When RBC cholinesterase activity is reduced by more than 25 % of normal,
clinical features tend to appear, and severity is more common when the levels go
below 90% of normal.
Despite these facts, serial studies and randomized control trials have failed
to document a strict relationship between the severity of clinical manifestations and
prognosis.
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LABORATORY FINDINGS
Poisoning is confirmed by demonstration of decreased erythrocyte or
butyrylcholinesterase activity, which needs to be hemoglobin standardised.
Standardized Erythrocyte acetylcholinesterase does not exhibit the same inter-
individual variability. The erythrocyte membrane contains erythrocyte
acetylcholinesterase. Thus, pre-intoxication enzyme activity levels are dependent
on formation of new erythrocytes (hematopoiesis - a process that extends from 90
to 120 days).
Butyrylcholinesterase is a acute-phase reactant which normalizes in twenty
to thirty days. Genetic variation can occurs in three percent of normal population,
causing baseline decrease in butyrylcholinesterase activity level. Parenchymal liver
disease, congestive heart failure, metastatic carcinoma, pregnancy, and several
medications can give false negative values for butrylcholinesterase.
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Peradeniya organophosphorus poisoning (POP) scale:
The Peradeniya Organophosphorous Poisoning (POP) Scale was a
Scoring System introduced by Senanayake et al18 in 1993.Common clinical
manifestations of OP poisoning are assessed on a three-point scale varying from 0
to 2. A score of 0 to 3 is considered as mild poisoning, 4 to 7 as moderate
poisoning and 8 to 11 as severe poisoning.
Table 3:  peradeniya organophosphorus poisoning scale.
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MANAGEMENT:
Initial management:
Attention to the airway is the initial management in the
organophosphorus or carbamate poisoning. Oxygen and atropinization should be
done in the management of hypoxic symptoms like cyanosis, rales, excessive oral
secretions and bronchorrhea. Atropine should be given till there is no evidence of
pulmonary fluid and the secretions have dried.
Respiratory failure during atropinisation should be managed by continuous
suctioning, intubation and ventilation. During rapid sequence intubation (RSI) in
the organophosphorus poisoned patient, the use of a depolarizing agents like
succinyl choline, is not recommended since it may result in prolonged paralysis
because it is metabolized through butyrylcholinesterase.
Organophosphorus poisoning causes vasodilation resulting in significant
GI fluid losses. The management should be giving loading dose of 4 points NS so
that we can maintain a normal volume. When atropine and fluids are not able to
correct the hypotension vasopressors like phenylephrine is indicated.
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In case of seizures benzodiazepine agents like diazepam, lorazepam or
midazolam can be used.
Decontamination:
After initial stabilization decontamination should be done. Percutaneous
absorption of pesticides continues to take place via skin and mucous membrane.
Hence patient should be undressed and a thorough body wash should be given
which prevents more than 85% of pesticide absorption and antidote should be
given simultaneously.
Health care providers self protection and decontamination should be given
first priority in OP and nerve agent treatment. Adequate training should be given
to all the medical personnel participating in the treatment of organophosphor
poisoning. These health care providers should be adequately trained about safety
precautions and they should be provided with neoprene gloves and eye goggles.
There is a controversy remains regarding Gastro intestinal tract
decontamination. WHO recommends activated charcoal should be given in case of
insecticide poisoning.
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Activated charcoal
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Anti-cholinergic agents:
Atropine is the main antidote therapy for pesticide poisoning. Atropine
effectively crosses the blood brain barrier and it reverses the central and peripheral
muscuranic effects. Atropine is given in the dose of 2 mg loading followed by
double the dose for every five minutes which yeild a dose of 25 mg in 20 minutes
and 75mg in 25 minutes. Atropine should be give till signs of atropinisation like
disappearance of crackles in longs, heart rate more than 90/in and stable blood
pressure
Chemical structure of atropine
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Oximes:
Oximes: The enzyme acetylcholinesterase is inhibited by
Organophosphorus. Oximes are useful in the reactivation of acetylcholinestrase.
Pralidoxime was first introduced in middle of 1950 and it was first used in the
treatment of parathion poisoning. Though other oximes like obidoxime were
introduced, till now, only pralidoxime is widely used. Pralidoxime exists in four
types of salts of which most commonly used is chloride and iodide salts. Chloride
is preferred for iodide because it does not affect thyroid gland and it’s molecular
weight is less and it is five times potent than iodide salt.
Pralidoxime effectiveness largely depends on type and amount of pesticide
consumed. The effectiveness was doubted by a study19 conducted in Christian
Medical College which shows low dose of pralidoxime infusion is harmful, but
there may be bias in selecting the patient group, type of compound consumed and
time delay in treatment.
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Chemical structure of pralidoxime
Mechanism of action of pralidoxime
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Any oximes whether it is pralidoxime or obidoxime it should be given before
the onset of aspiration pneumonitis or before development of hypoxic ischemic
encephalopathy.
WHO recommends first a loading dose of pralidoxime of 2gms should be
given over one hour. Loading dose should be given slowly otherwise it will cause
severe vomiting and thereby increasing the risk of aspiration and other side effects
like tachycardia and increase in diastolic hypertension can occur. Following
loading dose pralidoxime should be maintained at a dose of 500mg/hour for at least
three days.
Obidoxime is usually given by intravenous route. If intravenous access is
not possible, it can be given by intramuscular route. Dose is 250 mg bolus
followed by 750 mg/24 hour maintenance dose given to attain a serum level of 20
micro moles/L. The common side effects of this compound include nausea,
headache, dizziness, paraethesia and pallor.
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Chemical structure of obidoxime
Asoxime is given in two doses as either 250 mg or 500 mg intramuscular
injection and it reaches the plasma concentration of 4mg/l in 4-6 mins which is
maintained for 125 mins in case of low dose and 200 mins in case of high dose. It
is given as i.m. injection four times a day along with atropine for 2-6 days.
A study20 done on twenty two healthy individuals didn’t reveal any side
effects when asoxime was given in the dose of 500 mg per oral. Asoxime is a
promising bispyridinium in the medical management following poisoning with
many nerve agents. The drawback of asoxime when compared with other oximes is
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the lack of stability in the aqueous solution. Asoxime is an effective antidote for
insecticide poisoning except in cases with complications like HIE or aspiration
pneumonitis, which is common in fast acting insecticides like parathion.
Chemical structure of asoxime.
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Prevention of OP Poisoning:
1. Prevention of insecticide poisoning is better than treatment because of risk in
treatment and high fatality rate;
2. There should be adequate ventilation and enough air circulation in the field
of insecticide spraying;
3. Don’t use the insecticide for indoor spraying if it was supposed to be used for
outdoor purpose only;
4. Follow the safety precautions in the product label;
5. Always try to use the products which are premixed;
6. Always keep the food products and drinking water away from the area of
vicinity of insecticide spraying;
7. Always thoroughly wash the fruits and vegetables before using;
~ 54 ~
8. Don’t use or recycle the insecticide containers for storing food and related
products;
9. Don’t store the insecticides in other containers;
10. Use protective googles and gloves while spraying insecticides;
11. Wash your hand with soap water after spraying insecticides;
12. Always store the insecticides in a separate store room and should be out of
reach for children;
13. Educate the children adequately about insecticides and its poisoning; and
14. Never dispose the insecticides and its remain in toilet or water drain, ponds
and river.
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MATERIAL AND METHOD
1. Patients admitted in general medicine department chengalpattu.
2.  Information collected through a preformed and pretested proforma.
3. Qualifying patients will undergo a detailed history, clinical examination and
biochemical analysis.
4.The propotions of the complications and mortality will be calculated using the
student T test for statiscal significance. SPSS/EPI INFO will be used for statistical
analysis.
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RESULTS
Table 4 :Distribution of patients according to their age group (N=110)
Bio-social
characteristics
No Percent
Age in years
20-40 61 55.45
40-60 35 31.81
>60 14 12.72
Range 21-75
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Chart 1: Distribution of patients according to their age group.
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Table 5 :Distribution of patients according to their sex (N=110)
Characteristics No Percent
Male 69 62.72
Female 41 37.27
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Chart 2 :Distribution of patients according to their sex
This study was done in Chengalpattu Medical College between above
mentioned duration with incidence of organophosphorus poisoning common
among males compared to females. Majority of patients were in the age group
of 20-40 years.
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Table 6:Distribution of patients according to the type of organophosphorus
compound consumed(N=110)
Type of
organophosphorus
compound
No. Percent
Chlorpyriphos 36 32.72
Dimethoate 19 17.27
Methyl parathion 21 19.09
Phorate 11 10
Quiniolphos 9 8.18
Others 14 12.72
~ 61 ~
Chart 3 :Distribution of patients according to the type of organophosphorus
compound consumed
Most common compound consumed was chlorpyriphos(32.72%)
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Table 7:Distribution of patients according to their peradeniya score(N=50)
Peradeniya score No Percent
Mild 22 20
Moderate 47 42.72
Severe 41 37.27
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Chart 4 :Distribution of patients according to their peradeniya score
Majority of patients had a moderate severity of organophosphorus poisoning
at presentation.
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Table 8:Distribution of patients according to their occupation(N=110)
Occupation No Percent
Student 15 13.63
Housewife 33 30
Farmer 42 38.18
Employee 15 13.63
None 5 4.5
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Chart 5: distribution of patients according to their occupation.
Majority of patients who consumed organophosphorus poisoning were farmer
by occupation.
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Table 9 :Distribution of patients according to their residence
Residence No Percent
Rural 73 66.36
Urban 37 33.63
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Chart 6: distribution of patients according to their residence.
Majority of patients who consumed organophosphorus poisoning were from
rural area.
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Table 10 :Distribution of patients according to their route of administration
Route No Percent
Oral 92 83.63
Inhalation 11 10
Others 7 6.36
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Chart 7 : distribution of patients according to their route of administration.
Route of administration of organophosphorus poisoning in majority of
patients was oral.
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Table 11:Manner of distribution of organophosphorus poisoning
Manner No Percent
Suicidal 101 91.81
Homicidal 0 0
Accidental 9 8.18
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Chart 8 :manner of distribution of organophosphorus poisoning.
In majority of cases manner of distribution of organophosphorus poisoning is
suicidal.
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Table 12: Distribution of patients according to the clinical features
Signs and Symptoms No Percent
Sweating 27 24.54
Vomiting 44 40
Diarrhea 76 69.09
Salivation 41 37.27
bradycardia 32 29.09
Miosis 98 89.09
Fasiculation 40 36.36
Abdominal pain 95 86.36
neck muscle weakness 16 14.54
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Chart 9: distribution of patients according to their symptoms
Most common clinical finding in patients was miosis followed by abdominal
pain and diarrhea.
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Table 13:Association of mild severity by peradeniya score of
organophosphorus(POP) with CPK,SGOT and SGPT.
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Chart10 : Association of mild severity by peradeniya score of
organophosphorus(POP) with CPK,SGOT and SGPT
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Table 14:Association of moderate severity by peradeniya score of
organophosphorus(POP) with CPK,SGOT and SGPT.
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Chart 11: Association of moderate severity by peradeniya score of
organophosphorus(POP) with CPK,SGOT and SGPT.
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Table 15: Association of severe severity by peradeniya score of
organophosphorus(POP) with CPK,SGOT and SGPT.
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Chart 12: Association of severe severity by peradeniya score of
organophosphorus(POP) with CPK,SGOT and SGPT.
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~ 80 ~Table 16:POP* levels of CPK crosstabulation.
~ 81 ~Table 17 :POP *levels of SGOT crosstabulation
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Table 18 : POP*levels of SGPT crosstbulation.
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Table 19: correlation of POP with levels of CPK,SGOT and SGPT.
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Table 20 : prognosis vs CPK levels crosstab.
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Table 21 : prognosis vs SGOT crosstab.
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Table 22 : prognosis vs SGPT crosstab.
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Table 23 :Association of respiratory failure in organophosphorus poisoning
with CPK,SGOT and SGPT.
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Chart 13: Association of respiratory failure in organophosphorus poisoning
with CPK,SGOT and SGPT.
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Table 24:Association of intermediate syndrome in organophosphorus
poisoning with CPK,SGOT and SGPT.
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Chart 14: Association of intermediate syndrome in organophosphorus
poisoning with CPK,SGOT and SGPT.
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Table 25:Association of death in organophosphorus poisoning with
CPK,SGOT and SGPT.
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Chart 15 : Association of death in organophosphorus poisoning with
CPK,SGOT and SGPT
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Discussion
Organophosphorus (OP) compounds are among the most commonly
used pesticides in agriculture. Because of their wide use and easy accessibility, OP
toxicity is important global health problem especially in many developing
countries like India.
The major toxicity of organophosphorus poisoning is due to the
inhibition of acetylcholinesterase and there by leading to the excess stimulation of
muscuranic and nicotinic receptors. Cholinergic symptoms develop fast which
forms the basis for clinical diagnosis which is confirmed by cholinesterase
inhibition. Cholinesterase levels are not done in all clinical labs and it is not
available in many parts of India, where clinical case load is very high. Present
study showed that out of 110 patients, 62.72% were males and 37.27% were
females. This study correlated well with study done by Dash et al.’s21 study, which
showed an incidence of 67% in males and 23% in females.
They were aged from 21 to 73 years, 66% came from rural areas,
whereas 34% from urban areas. Regarding occupation, 13.63% were students, 30%
housewives and 38.18% farmers. The most common route of exposure was oral
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route (83.63%), the most common manner of poisoning was suicidal manner
(91.1%), and the commonest OP compound was Chlorpyriphos (32.72%).
Weissmann-Brenner et al22 reported that 66% of patients with OP poisonings
were males and 34% were females, 39% were less than 10 years old, 64% of
exposure was accidental, 36% was suicidal and the most common route of
intoxication was oral (67%).
The present study illustrated that most of patients manifested with
miosis (89%), followed by abdominal pain (86%), diarrhea (69.09%) and vomiting
(40%). Increase of Sr. CPK levels reflects injury to a tissue of high CPK activity.
CPK level measurements are useful in the diagnosis of medical conditions like
myocardial infarction and skeletal muscle injuries, which are acute. Theories relate
this increased CPK levels to agitation, hyperactivity and drugs (i.e. rhabdomyolysis
and muscle necrosis). The present study showed that there was a high degree of
correlation between the initial serum CPK levels and the severity of acute OP
poisoning; as illustrated by the positive correlation of initial serum CPK level with
POP scale. These correlations were found to be statistically highly significant (P <
0.001).
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These results are in agreement with Bhattacharyya et al23 who
confirmed the presence of a high degree of correlation between initial CPK value
and POP scale. Muscle fiber necrosis and consequently raised CPK levels occur in
severely acute OP poisoned cases. So, cheaper, easily quantifiable and more
available biochemical markers in relation to OP poisoning like serum CPK can be
used in predicting as well as assessing the prognosis of patients with OP poisoning.
All the patients included in the study were classified according to
Peradeniya organophosphorus poisoning scale into mild (0-3), moderate (4-7) and
severe (8-11).Of the 110 patients who were studied 22 (20%) had mild, 47
(42.72%) had moderate and 41(37.27%) had severe level of poisoning.
The mean age group in the mild (36 years) and moderate (32.02 years)
severity patients were similar. However the mean age group in the severe age
group was 51.48 years, suggesting that the older age group have a severe degree of
poisoning. There was not much variation in distribution of severity between males
and females. The severity of OP poisoning in this study ranged from mild,
moderate and severe; most of cases were presented with moderate OP toxicity.
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Various authors Illustrated that the POP scale can efficiently predict the
severity of OP poisoned patients. Muscle injury in insecticide poisoning occurs in
three types.  Type 1 is because of continuous depolarization at NM junction, type 2
is intermediate syndrome and type 3 is delayed polyneuropathy. In the present
work, the elevated serum CPK levels were confirmed during the acute stage of
toxicity i.e. all cases presented within 6 hours of exposure to OP compounds and
before the development of the intermediate syndrome.
This was in agreement with authors who confirmed in their study on OP
intoxicated patients that serum CPK level is elevated even in the absence of
intermediate syndrome presumably due to muscle fiber necrosis. Intermediate
syndrome occurs in between the periods of acute and delayed OP toxicity. In
majority of cases, intermediate syndrome occurs in between 24–72 hours after
acute organophosphorus poisoning. Meanwhile authors had linked the raised CPK
levels to the rhabdomyolysis in intermediate syndrome. The excess acetylcholine
seen in OP poisoning leads to reversible myocyte injury and rise of different
muscle enzymes, including CPK. The present work highlighted the importance of
measurement of serum CPK levels, as it might be helpful in predicting as well as
assessing the prognosis of patients with acute OP poisoning.
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The present study found that the initial serum CPK level is
comparable for BChE level and can be used as an alternative biomarker in
diagnosis of acute OP poisoning, provided that exclusion of any other diseases or
conditions that may cause rise in CPK levels, these results were statistically
significant (p < 0.05). This was in agreement with Perreault et al24 who confirmed
that when a skeletal muscle is injured, CPK leaks into the blood and urine. Serum
CPK level remains the best biomarker for detecting and monitoring skeletal muscle
damage and diseases. Also authors confirmed the elevation of serum CPK levels in
acute OP poisoning, especially if the patient is severely poisoned, presumably due
to muscle fiber necrosis.
However, the main disadvantage of serum CPK as a biomarker for
acute OP poisoning, its non-specificity. So, exclusion of other conditions and
diseases that may cause its elevation in patients with acute OP poisoning is
mandatory. Sniderman25 stated that numerous factors have influence on CPK
activity, so the suitability of CPK as a biomarker for diagnosis of muscle injury
and disease should be viewed with caution. Also, researches illustrated that there
are multiple causes of elevated CPK, which may affect its reliability as a
biomarker. Also, further studies with greater number of patients and in other
locations are required to support the present observations, since the present work
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was conducted on a relatively small number of patients, and in only one poisoning
control unit, with most of cases were presented with moderate OP toxicity, and
CPK levels are commonly elevated in severely intoxicated patients.
Liver accepts and metabolizes organophosphates through oxidation and
Sulfate or glucuronate conjugation and may undergo oxidative damage in case of
organophosphorus poisoning. Hence, liver function test like SGOT and SGPT
values are raised in case severe organophosphorus poisning.
In this study SGOT when compared to SGPT is abnormal in more case
of organophosphorus poisoning and their increase depends on type of compound
consumed. Main limitation of liver function test is underlying silent chronic liver
disease cannot be ruled out and its non specificity.
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Limitation of the study
1) Sample size was small.
2) The amount of compound ingested and time elapsed after consuming the
poison has not been considered.
3) An underlying chronic liver disease or myopathy cannot be ruled out which
might have altered the results.
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SUMMARY
1) In this study which included 110 patients of organophosphorus poisoning
brought to Chengalpattu Medical College hospital, 62.72% were males
and 37.27% were females.
2) Majority of the patients were in the age group of 20 -40 which
constituted 61% of the study population.
3) The severe poisoning group predominantly belonged to older population
with a mean age 51.48 years when compared to mild 36 years and
moderate 32.02 years.
4) Most common compound consumed was chlorpyrifos (32.72%) followed
by methylparathion (19.09%) and dimethoate (17.27%).
5) Most common presenting symptom is abdominal pain (86.36%) and most
common presenting sign is miosis (89.09%).
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6) Mean CPK, SGOT and SGPT values in case of mild, moderate and
severe case of OPC poisoning is 76.5, 38.63 and 45.0 respectively.
7) Mean CPK, SGOT and SGPT values in case of moderate severity in case
of OPC poisoning is 249.24, 71.53 and 70.44 respectively.
8) Mean CPK, SGOT and SGPT values in case of severe poisoning is
843.68, 157.54 and 138.32 respectively.
9) Mean CPK, SGOT, SGPT values in case of respiratory failure,
intermediate syndrome and death is (815.10, 157.84, 141.57), (857.2,
159.4, 143.40), (940.81, 183.37, 160.37) respectively.
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PROFORMA
PATIENT DETAILS
NAME:
AGE:
SEX:
DATE OF ADMISSION:
WARD NO:
IP NO:
HISTORY
Nature of compound consumed
Time and place
Occupation
Residence address
Route of administration
Manner of administration
Clinical features
Symptoms
Central nervous system symptoms
Muscuranic symptoms
Nicotinic symptoms
Vitals:
BP:                 PULSE:                   RR:
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PERADENIYA SCALE OF ORGANOPHOSPHORUS POISONING:
MILD:                             MODERATE: SEVERE:
INVESTIGATIONS:
HB/TC/DC/ESR
ECG
RANDOM BLOOD SUGAR
BLOOD UREA
SERUM CREATININE
SERUM CREATINE KINASE
LFT
1)SGOT
2)SGPT
TREATMENT GIVEN
STOMACH WASH
ACTIVATED CHARCOAL
ATROPINE
PRALIDOXIME
SUPPORTIVE MANAGEMENT
VENTILATORY SUPPORT
NUMBER OF DAYS IN HOSPITAL:
OUTCOME:
s no 110 age occupation residence route
male 69 20-40 61 none 5 rural 73 oral
female 41 40-60 35 student 15 urban 37 inhalation
>60 14 house wife 33 others
farmer 42
employee 15
29
28
24
33
35
36
23
26
28
21
31
32
36
36
37
31
26
28
25
24
30
37
39
40
21
manner organophosphorous signs and symptoms pop scale
92 suicidal 101 Dimethoate 19 sweating 27 mild
11 homicidal 0 methyl parathion 21 vomiting 44 moderate
7 accidental 9 chlorpyrifos 36 diarrrhoea 76 severe
phorate 11 salivation 41
Quiniolphos 9 bradycardia 32
others 14 miosis 98
fasciculations 40
neck muscle weakness 16
abdominal pain 95
29
28
24
33
35
36
23
26
28
21
31
32
36
36
37
31
26
28
25
24
30
37
39
40
21
day 1 mean serum CPK levels day 1  LFT SGOT
22 mild 99 moderate 289.5 severe 687.5 mild 44
47 43 110 62 189.5 65 777 25
41 48 112.5 46 301 71 967.5 37
51 88.5 47 333.5 68 1009.5 48
59 56.5 43 275 63 786.5 66
38 33.5 42 222 66 885 23
39 111 28 278 72 955 18
32 68.5 33 387.5 67 698.5 14
35 67.5 35 288.5 73 812.5 37
36 91.5 36 199.5 63 944 49
34 77 35 189 69 1050 33
36 121.5 26 245 46 663 46
23 44 28 312 56 771.5 39
36 29 26 221.5 55 821.5 55
38 51.5 28 287 42 831.5 42
29 90 29 192 43 902.5 30
28 108 30 247.5 44 788.5 19
24 82.5 23 267.5 47 921.5 22
33 55.5 26 289 48 955 76
35 71 33 187.5 49 1028 40
36 61 37 199 50 1078 38
23 119.5 29 192 51 754.5 49
26 28 201 41 564.5
24 208 42 650.5
33 188.5 46 832
35 300.5 48 948.5
36 263 51 739
23 221 52 1060.5
26 133.5 57 884
29 223.5 55 756.5
27 319 44 693.5
28 294.5 48 847
21 273.5 49 691.5
31 227 45 1100
32 210.5 53 912.5
36 256 54 830
36 241.5 57 770
37 323.5 37 826
31 245 39 913
26 230.5 40 822
28 331.5 21 661.5
25 178.5 27
24 220.5
30 311.5
37 221
39 199
40 299.5
21
SGPT SGOT SGPT
55 moderate 109 99
39 89 76
55 75 70
58 55 60
73 111 102
26 77 80
38 94 92
33 112 110
53 87 79
60 34 37
45 57 60
44 84 74
49 84 72
59 36 40
36 57 55
22 46 48
10 59 60
20 119 110
71 78 79
48 67 68
41 35 36
55 67 69
58 60
36 40
49 50
77 73
56 58
39 44
47 43
80 74
66 70
44 45
19 26
89 90
60 58
48 50
110 109
150 146
90 102
46 51
60 63
48 49
38 42
142 118
113 103
98 106
67 65


